These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16416778)

  • 1. [Carrier testing].
    Kawame H
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():99-103. PubMed ID: 16416778
    [No Abstract]   [Full Text] [Related]  

  • 2. Reproductive empowerment: the main motivator and outcome of carrier testing.
    Lewis C; Skirton H; Jones R
    J Health Psychol; 2012 May; 17(4):567-78. PubMed ID: 21917912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the elaboration of diagnostic genetic reports in the clinical setting.
    Oriola J; Carrasco P; Díez O; Ezquieta B; ;
    Med Clin (Barc); 2019 Oct; 153(7):293-297. PubMed ID: 31395279
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic accuracy: theoretical models for preimplantation genetic testing of a single nucleus using the fluorescence in situ hybridization technique.
    Scriven PN; Bossuyt PM
    Hum Reprod; 2010 Oct; 25(10):2622-8. PubMed ID: 20675683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive survey of mutations in RP2 and RPGR in patients affected with distinct retinal dystrophies: genotype-phenotype correlations and impact on genetic counseling.
    Pelletier V; Jambou M; Delphin N; Zinovieva E; Stum M; Gigarel N; Dollfus H; Hamel C; Toutain A; Dufier JL; Roche O; Munnich A; Bonnefont JP; Kaplan J; Rozet JM
    Hum Mutat; 2007 Jan; 28(1):81-91. PubMed ID: 16969763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic counseling].
    Pietrzyk JJ
    Pediatr Pol; 1976 Apr; 51(4):455-61. PubMed ID: 772579
    [No Abstract]   [Full Text] [Related]  

  • 7. [Improvements in the diagnosis of dystrophinopathies: what have we learnt in these last 20 years?].
    López-Hernández LB; Ayala-Madrigal ML; van Heusden D; Estrada-Mena FJ; Canto P; Sandoval-Ramírez L; Gómez-Díaz B; Coral-Vázquez RM
    Rev Neurol; 2011 Feb; 52(4):239-49. PubMed ID: 21312170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome.
    Nagel M; Nagorka S; Gross O
    Hum Mutat; 2005 Jul; 26(1):60. PubMed ID: 15954103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-implantation genetic testing.
    Grace J; El Toukhy T; Braude P
    BJOG; 2004 Nov; 111(11):1165-73. PubMed ID: 15521860
    [No Abstract]   [Full Text] [Related]  

  • 10. Genotype-phenotype correlations in L1 syndrome: a guide for genetic counselling and mutation analysis.
    Vos YJ; de Walle HE; Bos KK; Stegeman JA; Ten Berge AM; Bruining M; van Maarle MC; Elting MW; den Hollander NS; Hamel B; Fortuna AM; Sunde LE; Stolte-Dijkstra I; Schrander-Stumpel CT; Hofstra RM
    J Med Genet; 2010 Mar; 47(3):169-75. PubMed ID: 19846429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes regarding carrier testing in incompetent children: a survey of European clinical geneticists.
    Borry P; Goffin T; Nys H; Dierickx K
    Eur J Hum Genet; 2007 Dec; 15(12):1211-7. PubMed ID: 17712355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked adrenoleukodystrophy: diagnostic and follow-up system in Japan.
    Shimozawa N; Honda A; Kajiwara N; Kozawa S; Nagase T; Takemoto Y; Suzuki Y
    J Hum Genet; 2011 Feb; 56(2):106-9. PubMed ID: 21068741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations.
    Grimm T
    Am J Med Genet; 1984 Aug; 18(4):719-23. PubMed ID: 6486170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Presymptomatic testing and predictive testing].
    Sakurai A
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():93-8. PubMed ID: 16416777
    [No Abstract]   [Full Text] [Related]  

  • 15. Policy recommendations for carrier testing and predictive testing in childhood: a distinction that makes a real difference.
    Hogben S; Boddington P
    J Genet Couns; 2005 Aug; 14(4):271-81. PubMed ID: 16047090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of mosaic retinal dysfunction in choroideremia carriers electroretinographic and psychophysical testing.
    Vajaranant TS; Fishman GA; Szlyk JP; Grant-Jordan P; Lindeman M; Seiple W
    Ophthalmology; 2008 Apr; 115(4):723-9. PubMed ID: 18201765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation for X-linked thrombocytopenia from a mild symptomatic carrier.
    Okuya M; Kurosawa H; Kubota T; Endoh K; Ogiwara A; Nonoyama S; Hagisawa S; Sato Y; Matsushita T; Fukushima K; Sugita K; Sato T; Arisaka O
    Bone Marrow Transplant; 2010 Mar; 45(3):607-9. PubMed ID: 19684625
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for the fragile X syndrome: the necessity of international guidelines for molecular genetics predictive testing in general.
    Fryns JP
    Genet Couns; 1995; 6(4):293-6. PubMed ID: 8775414
    [No Abstract]   [Full Text] [Related]  

  • 19. Electrophysiology extends the phenotypic spectrum of X-linked myopathy with excessive autophagy.
    Munteanu I; Ackerley CA; Mnatzakanian GN; Kissel JT; Minassian BA
    Neurology; 2005 Mar; 64(5):927-8. PubMed ID: 15753448
    [No Abstract]   [Full Text] [Related]  

  • 20. Unique considerations for genetic counseling in community-based carrier screening programs.
    Rimoin DL; Greenwald S; Nathan TJ; Kaback MM
    Prog Clin Biol Res; 1977; 18():297-304. PubMed ID: 601081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.